Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Antimicrobial Agents and Chemotherapy|December 15, 2010
Auranofin protects against anthrax lethal toxin-induced activation of the Nlrp1b inflammasomeZachary L Newman, Nicole Sirianni, Christina Mawhinney, et al.Blood|July 19, 2003
The amino terminal and E2F interaction domains are critical for C/EBP alpha-mediated induction of granulopoietic development of hematopoietic cellsFrancesco D'Alo', Lisa M Johansen, Erik A Nelson, et al.Molecular Systems Biology|June 10, 2010
Chemical combinations elucidate pathway interactions and regulation relevant to Hepatitis C replicationChristopher M Owens, Christina Mawhinney, Jill M Grenier, et al.Plos One|February 27, 2013
Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infectionCharles J Shoemaker, Kathryn L Schornberg, Sue E Delos, et al.Journal of Virology|April 30, 2003
EBNA2 and activated Notch induce expression of BATFLisa M Johansen, Christopher D Deppmann, Kimberly D Erickson, et al.Blood|July 20, 2002
Heterozygous PU.1 mutations are associated with acute myeloid leukemiaBeatrice U Mueller, Thomas Pabst, Motomi Osato, et al.Nature Biotechnology|July 8, 2009
Synergistic drug combinations tend to improve therapeutically relevant selectivityJoseph Lehár, Andrew S Krueger, William Avery, et al.Science Translational Medicine|June 21, 2013
FDA-approved selective estrogen receptor modulators inhibit Ebola virus infectionLisa M Johansen, Jennifer M Brannan, Sue E Delos, et al.Antimicrobial Agents and Chemotherapy|May 21, 2014
Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infectionJulie Dyall, Christopher M Coleman, Brit J Hart, et al.Antimicrobial Agents and Chemotherapy|January 20, 2021
Inhibition of Arenaviruses by Combinations of Orally Available Approved DrugsShawn Herring, Jessica M Oda, Jessica Wagoner, et al.Pageof 2